DUSP1 promoter methylation in peripheral blood leukocyte is associated with triple-negative breast cancer risk

Abstract

DNA methylation is one of the most common epigenetic alterations, providing important information regarding cancer risk and prognosis. A case-control study (423 breast cancer cases, 509 controls) and a case-only study (326 cases) were conducted to evaluate the association of DUSP1 promoter methylation with breast cancer risk and clinicopathological… (More)
DOI: 10.1038/srep43011

Topics

  • Presentations referencing similar topics